| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.009 |
| mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.009 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.009 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.01 |
| mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |
| mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.01 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |